Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582699 · ClinicalTrials.gov registry record
Depression, Cytokines and Pancreatic Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 80
- Enrollment target
NCT00582699: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582699 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582699 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to measure certain specific chemicals in your blood, produced by the body in response to a stress, such as having pancreatic cancer. These chemicals are called "cytokines" and the researchers doing this study want to look at the role they may play in developing depression.
Interventions
- BEHAVIORAL assessment interview and blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-11 |
| Est. Completion | 2014-04 |
What the finished NCT00582699 record still lists
NCT00582699 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which assessment interview and blood draw is the first listed.
NCT00582699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582699 about?
NCT00582699 is a clinical study titled "Depression, Cytokines and Pancreatic Cancer". The purpose of this study is to measure certain specific chemicals in your blood, produced by the body in response to a stress, such as having pancreatic cancer. These chemicals are called "cytokines" and the researchers doing this study want to look at the role they may play in developing depressio...
What is the current status of trial NCT00582699?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2005-11. Estimated completion is 2014-04.
What interventions are being tested in trial NCT00582699?
The interventions under investigation include: assessment interview and blood draw (BEHAVIORAL).
Who is sponsoring clinical trial NCT00582699?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia